3 Rules Health Systems Are Living By in 2025

Healthcare experts shared key principles that are guiding health system strategy during a panel at MedCity News’ INVEST conference. These leaders believe in flexible, patient-centered engagement strategies, emphasize clinical value as the benchmark for adopting technology, and champion collaboration to scale solutions that deliver proven results. The post 3 Rules Health Systems Are Living By…

Read More

Are GLP-1s Worth the Hype?

GLP-1s have proven to be highly effective for weight loss but pose significant cost challenges for employers, according to a recent panel of experts at MedCity INVEST. The post Are GLP-1s Worth the Hype? appeared first on MedCity News.

Read More

Proposed Medicaid Federal Match Penalty for States that Have Expanded Coverage for Immigrants: State-by-State Estimates

This analysis examines the potential impacts of a provision in the House reconciliation bill that proposes reducing the federal matching rate for the Affordable Care Act (ACA) Medicaid expansion population from 90% to 80% for states that either provide health coverage or financial assistance to purchase health coverage to individuals who are not “a qualified…

Read More

Inequalities in CAR T-Cell Therapy Access for US Patients with Relapsed/Refractory DLBCL

That is the title of my recent publication with co-authors Andrea Chung, Sachin Vadgama, Kristen Hurley, Miguel-Angel Perales, Leonard Clarkson Alsfeld, Sanjana Muthukrishnan and Anik R Patel, Gunjan L Shah, Richard T Maziarz. The abstract is below. CAR T-cell therapy has shown curative potential for patients with diffuse large B-cell lymphoma (DLBCL) and other malignancies,…

Read More